PTX3 binds MD-2 and promotes TRIF-dependent immune protection in aspergillosis

Journal of Immunology

Volumn 193, Issue 5, 2014, Pages 2340-2348

  Bozza, Silvia ^a   Campo, Silvia ^b   Arseni, Brunilde ^b   Inforzato, Antonio ^b   Ragnar, Lindstedt ^b   Bottazzi, Barbara ^c   Mantovani, Alberto ^c   Moretti, Silvia ^a   Oikonomous, Vasileios ^a   De Santis, Rita ^b   Carvalho, Agostinho ^a   Salvatori, Giovanni ^b   Romani, Luigina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Sigma Tau SpA   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; PENTRAXIN 3; PROTEIN MD 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; BETA INTERFERON; C REACTIVE PROTEIN; IL10 PROTEIN, HUMAN; IL10 PROTEIN, MOUSE; LY96 PROTEIN, HUMAN; LY96 PROTEIN, MOUSE; NERVE PROTEIN; NEURONAL PENTRAXIN; SERUM AMYLOID P; TICAM-1 PROTEIN, MOUSE; TICAM1 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TLR4 PROTEIN, MOUSE; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; DRUG PROTEIN BINDING; FEMALE; HUMAN; HUMAN CELL; IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; LUNG ASPERGILLOSIS; MOUSE; NEUTROPHIL; NONHUMAN; SIGNAL TRANSDUCTION; ANIMAL; ASPERGILLOSIS; BAGG ALBINO MOUSE; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; C-REACTIVE PROTEIN; HEK293 CELLS; HUMANS; INTERFERON-BETA; INTERLEUKIN-10; LYMPHOCYTE ANTIGEN 96; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; SERUM AMYLOID P-COMPONENT; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84907026947     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400814     Document Type: Article

References (41)

1. Kontoyiannis, D. P., K. A. Marr, B. J. Park, B. D. Alexander, E. J. Anaissie, T. J. Walsh, J. Ito, D. R. Andes, J. W. Baddley, J. M. Brown, et al. 2010. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin. Infect. Dis. 50: 1091-1100.
2. Pagano, L., M. Caira, A. Nosari, M. T. Van Lint, A. Candoni, M. Offidani, T. Aloisi, G. Irrera, A. Bonini, M. Picardi, et al. 2007. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin. Infect. Dis. 45: 1161-1170.
3. Pappas, P. G., B. D. Alexander, D. R. Andes, S. Hadley, C. A. Kauffman, A. Freifeld, E. J. Anaissie, L. M. Brumble, L. Herwaldt, J. Ito, et al. 2010. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin. Infect. Dis. 50: 1101-1111.
4. Romani, L. 2011. Immunity to fungal infections. Nat. Rev. Immunol. 11: 275-288.
5. Bellocchio, S., C. Montagnoli, S. Bozza, R. Gaziano, G. Rossi, S. S. Mambula, A. Vecchi, A. Mantovani, S. M. Levitz, and L. Romani. 2004. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol. 172: 3059-3069.
6. Bochud, P. Y., J. W. Chien, K. A. Marr, W. M. Leisenring, A. Upton, M. Janer, S. D. Rodrigues, S. Li, J. A. Hansen, L. P. Zhao, et al. 2008. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N. Engl. J. Med. 359: 1766-1777.
7. Carvalho, A., C. Cunha, A. Carotti, T. Aloisi, O. Guarrera, M. Di Ianni, F. Falzetti, F. Bistoni, F. Aversa, L. Pitzurra, et al. 2009. Polymorphisms in Tolllike receptor genes and susceptibility to infections in allogeneic stem cell transplantation. Exp. Hematol. 37: 1022-1029.
8. Carvalho, A., A. C. Pasqualotto, L. Pitzurra, L. Romani, D. W. Denning, and F. Rodrigues. 2008. Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J. Infect. Dis. 197: 618-621.
9. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189: 1777-1782.
10. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433.
11. Akashi, S., S. Saitoh, Y. Wakabayashi, T. Kikuchi, N. Takamura, Y. Nagai, Y. Kusumoto, K. Fukase, S. Kusumoto, Y. Adachi, et al. 2003. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J. Exp. Med. 198: 1035-1042.
12. Gray, P., J. Dagvadorj, K. S. Michelsen, C. Brikos, A. Rentsendorj, T. Town, T. R. Crother, and M. Arditi. 2011. Myeloid differentiation factor-2 interacts with Lyn kinase and is tyrosine phosphorylated following lipopolysaccharideinduced activation of the TLR4 signaling pathway. J. Immunol. 187: 4331-4337.
13. Inohara, N., and G. Nuñez. 2002. ML-a conserved domain involved in innate immunity and lipid metabolism. Trends Biochem. Sci. 27: 219-221.
14. Tissières, P., and J. Pugin. 2009. The role of MD-2 in the opsonophagocytosis of Gram-negative bacteria. Curr. Opin. Infect. Dis. 22: 286-291.
15. Gray, P., K. S. Michelsen, C. M. Sirois, E. Lowe, K. Shimada, T. R. Crother, S. Chen, C. Brikos, Y. Bulut, E. Latz, et al. 2010. Identification of a novel human MD-2 splice variant that negatively regulates Lipopolysaccharide-induced TLR4 signaling. J. Immunol. 184: 6359-6366.
16. Wang, X., P. M. Grace, M. N. Pham, K. Cheng, K. A. Strand, C. Smith, J. Li, L. R. Watkins, and H. Yin. 2013. Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain. FASEB J. 27: 2713-2722.
17. Cai, S., R. L. Zemans, S. K. Young, G. S. Worthen, and S. Jeyaseelan. 2009. Myeloid differentiation protein-2-dependent and-independent neutrophil accumulation during Escherichia coli pneumonia. Am. J. Respir. Cell Mol. Biol. 40: 701-709.
18. Jain, A. V., Y. Zhang, W. B. Fields, D. A. McNamara, M. Y. Choe, G. H. Chen, J. Erb-Downward, J. J. Osterholzer, G. B. Toews, G. B. Huffnagle, and M. A. Olszewski. 2009. Th2 but not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans infection. Infect. Immun. 77: 5389-5399.
19. Kurt-Jones, E. A., L. Popova, L. Kwinn, L. M. Haynes, L. P. Jones, R. A. Tripp, E. E. Walsh, M. W. Freeman, D. T. Golenbock, L. J. Anderson, and R. W. Finberg. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1: 398-401.
20. Bottazzi, B., A. Doni, C. Garlanda, and A. Mantovani. 2010. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu. Rev. Immunol. 28: 157-183.
21. Garlanda, C., E. Hirsch, S. Bozza, A. Salustri, M. De Acetis, R. Nota, A. Maccagno, F. Riva, B. Bottazzi, G. Peri, et al. 2002. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 420: 182-186.
22. Nauta, A. J., B. Bottazzi, A. Mantovani, G. Salvatori, U. Kishore, W. J. Schwaeble, A. R. Gingras, S. Tzima, F. Vivanco, J. Egido, et al. 2003. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur. J. Immunol. 33: 465-473.
23. Deban, L., H. Jarva, M. J. Lehtinen, B. Bottazzi, A. Bastone, A. Doni, T. S. Jokiranta, A. Mantovani, and S. Meri. 2008. Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation. J. Immunol. 181: 8433-8440.
24. Ma, Y. J., A. Doni, T. Hummelshøj, C. Honoré, A. Bastone, A. Mantovani, N. M. Thielens, and P. Garred. 2009. Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition. J. Biol. Chem. 284: 28263-28275.
25. D'Angelo, C., A. De Luca, T. Zelante, P. Bonifazi, S. Moretti, G. Giovannini, R. G. Iannitti, S. Zagarella, S. Bozza, S. Campo, et al. 2009. Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease. J. Immunol. 183: 4609-4618.
26. Moalli, F., A. Doni, L. Deban, T. Zelante, S. Zagarella, B. Bottazzi, L. Romani, A. Mantovani, and C. Garlanda. 2010. Role of complement and Fcgamma receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood 116: 5170-5180.
27. Bozza, S., F. Bistoni, R. Gaziano, L. Pitzurra, T. Zelante, P. Bonifazi, K. Perruccio, S. Bellocchio, M. Neri, A. M. Iorio, et al. 2006. Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood 108: 3387-3396.
28. Visintin, A., A. Mazzoni, J. A. Spitzer, and D. M. Segal. 2001. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 98: 12156-12161.
29. de Luca, A., S. Bozza, T. Zelante, S. Zagarella, C. D'Angelo, K. Perruccio, C. Vacca, A. Carvalho, C. Cunha, F. Aversa, and L. Romani. 2010. Nonhematopoietic cells contribute to protective tolerance to Aspergillus fumigatus via a TRIF pathway converging on IDO. Cell. Mol. Immunol. 7: 459-470.
30. Tissières, P., I. Dunn-Siegrist, M. Schäppi, G. Elson, R. Comte, V. Nobre, and J. Pugin. 2008. Soluble MD-2 is an acute-phase protein and an opsonin for Gram-negative bacteria. Blood 111: 2122-2131.
31. Carvalho, A., C. Cunha, R. G. Iannitti, A. De Luca, G. Giovannini, F. Bistoni, and L. Romani. 2012. Inflammation in aspergillosis: the good, the bad, and the therapeutic. Ann. N. Y. Acad. Sci. 1273: 52-59.
32. Bonifazi, P., C. D'Angelo, S. Zagarella, T. Zelante, S. Bozza, A. De Luca, G. Giovannini, S. Moretti, R. G. Iannitti, F. Fallarino, et al. 2010. Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis. Mucosal Immunol. 3: 193-205.
33. Inforzato, A., P. C. Reading, E. Barbati, B. Bottazzi, C. Garlanda, and A. Mantovani. 2012. The "sweet" side of a long pentraxin: how glycosylation affects PTX3 functions in innate immunity and inflammation. Front. Immunol. 3: 407.
34. Deban, L., R. C. Russo, M. Sironi, F. Moalli, M. Scanziani, V. Zambelli, I. Cuccovillo, A. Bastone, M. Gobbi, S. Valentino, et al. 2010. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat. Immunol. 11: 328-334.
35. Ortega, M., M. Rovira, X. Filella, M. Almela, J. Puig de la Bellacasa, E. Carreras, and J. Mensa. 2004. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation. Br. J. Haematol. 126: 372-376.
36. Romani, L., F. Fallarino, A. De Luca, C. Montagnoli, C. D'Angelo, T. Zelante, C. Vacca, F. Bistoni, M. C. Fioretti, U. Grohmann, et al. 2008. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211-215.
37. Iannitti, R. G., A. Carvalho, C. Cunha, A. De Luca, G. Giovannini, A. Casagrande, T. Zelante, C. Vacca, F. Fallarino, P. Puccetti, et al. 2013. Th17/ Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines. Am. J. Respir. Crit. Care Med. 187: 609-620.
38. Cunha, C., F. Aversa, J. F. Lacerda, A. Busca, O. Kurzai, M. Grube, J. Löffler, J. A. Maertens, A. S. Bell, A. Inforzato, et al. 2014. Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. N. Engl. J. Med. 370: 421-432.
39. Inforzato, A., A. Doni, I. Barajon, R. Leone, C. Garlanda, B. Bottazzi, and A. Mantovani. 2013. PTX3 as a paradigm for the interaction of pentraxins with the complement system. Semin. Immunol. 25: 79-85.
40. Jeannin, P., B. Bottazzi, M. Sironi, A. Doni, M. Rusnati, M. Presta, V. Maina, G. Magistrelli, J. F. Haeuw, G. Hoeffel, et al. 2005. Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 22: 551-560.
41. Raghavan, B., S. F. Martin, P. R. Esser, M. Goebeler, and M. Schmidt. 2012. Metal allergens nickel and cobalt facilitate TLR4 homodimerization independently of MD2. EMBO Rep. 13: 1109-1115.